a
Three United States Senators have sent Medtronic a letter, asking for information about how it tracks medical devices after releasing them on the market, according to a Star Tribune report.
Share prices for orthopedic and spine device companies have been on the downturn since last weekend, when the Centers for Medicare and Medicaid Services released a new pre-reimbursement review project, according to a Mass Device report.
The Oregon Evidence-based Practice Center at Oregon Health & Sciences University in Portland has been selected as one of two research centers that will independently review clinical studies on rhBMP-2, according to an OHSU news release.
Published in Spine
Medtronic recently launched its T2 Altitude Expandable Corpectomy Device in the United States and Europe, according to a Medtronic news release.
Medtronic recently reported second quarter revenue of $4.1 billion, a 6 percent increase over the second quarter of last year, according to a Medtronic news release.
The FDA approved Medtronic's AdaptiveStim with the RestoreSensor neurostimulation system, according to a Medtronic news release.
Published in Pain Management
A study led by Eugene Carragee, MD, recently presented at the North American Spine Society annual meeting, examined 12 industry-sponsored studies on the safety and efficacy of recombinant bone morphogenic protein-2 and found that no adverse events were reported in any of the studies.
Published in Spine
Medtronic has launched its T2 Altitude Expandable Corpectomy Device in the United States and Europe, according to a Medtronic news release.
Eight leading spine surgeons and industry experts discuss Medtronic's recombinant bone morphogenic-2 product Infuse and how the recent controversy over complication disclosures is impacting its use.
Published in Spine
Companies & Markets released a report forecasting growth in the spinal surgery device market to reach $12.6 billion by 2017 at a CAGR of 10 percent.
Page 6 of 10